CUSIP 03843E104COMAQSTQ4 2025
15 filings · latest Nov 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bratton Capital Management, L.P. | 9.81M | $63.38M |
| 2 | Blackrock, Inc. | 7.78M | $50.23M |
| 3 | Rtw Investments, LP | 6.25M | $40.38M |
| 4 | Vanguard Group Inc | 5.89M | $38.06M |
| 5 | Ecor1 Capital, LLC | 2.63M | $16.96M |
| 6 | Samsara Biocapital, LLC | 2.50M | $16.15M |
| 7 | State Street Corp | 2.46M | $15.91M |
| 8 | Geode Capital Management, LLC | 2.37M | $15.30M |
| 9 |
| 4 | Feb 13, 2025 | Bratton Douglas K | 13G/A | 11.1% | 10.08M | SEC |
| 5 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 2.9% | 2.75M | SEC |
| 6 | Nov 8, 2024 | Blackrock, Inc. | 13G | 6.4% | 5.82M | SEC |
| 7 | Oct 22, 2024 | Blackrock, Inc. | 13G | 6.4% | 5.82M | SEC |
| 8 | Apr 1, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G | 6.5% | 5.56M | SEC |
| 9 | Feb 14, 2024 | Armistice Capital, LLC | 13G | 5.9% | 3.92M | SEC |
| 10 | Feb 11, 2022 | Bratton Douglas K | 13G/A | 8.6% | 3.47M | SEC |
See the full Schedule 13D/13G history for Aquestive Therapeutics Inc.
Unlock full history| 2.03M |
| $13.13M |
| 10 | Morgan Stanley | 1.76M | $11.36M |